WASHINGTON – Today, the Drug Enforcement Administration announced the results of a week-long operational enforcement action as part of a whole-of-government initiative aimed at removing dangerous and illegal vaping substances from communities across America. During the operation, DEA seized more than 2.3 million vape devices and cartridges and more than...

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...

Washington, D.C. - Yesterday, a federal jury in Maryland convicted two El Salvadorian nationals for conspiring to participate in La Mara Salvatrucha, a transnational criminal enterprise, commonly known as MS-13. Junior Noe Alvarado-Requeno, aka Insolente, aka Trankilo, 25, and Miguel Angel Corea Diaz, aka Reaper, 39, were convicted of multiple...

FORT LAUDERDALE, Fla. – The Drug Enforcement Administration, Department of Defense, and Department of Homeland Security, and U.S. Coast Guard announced today a significant offload of drugs seized in international waters in the Eastern Pacific Ocean and Caribbean Sea. Agents with the DEA and the crew of the USCG Cutter...

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...

CORONADO , Calif. – On July 11, 2019, Vice President Mike Pence, Office of National Drug Control Policy Director James W. Carroll, Drug Enforcement Administration Acting Administrator Uttam Dhillon, and Vice Admiral Linda Fagan, commander of Coast Guard Pacific Area, attended a United States Coast Guard drug offload at Naval...

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...